Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

felcisetrag

A serotonin (5-HT) type 4 receptor agonist with potential gastrointestinal (GI) prokinetic activity. Upon administration, felcisetrag targets and binds to 5-HT4, thereby enhancing its activity. This may enhance GI motility, decrease GI tract and colonic transit time and improve constipation.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:5-HT4 agonist TAK-954
serotonin 4 receptor agonist TAK-954
serotonin agonist TAK-954
Code name:TAK 954
TAK-954
TD-8954
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search